Literature DB >> 15684604

Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.

Gregory L Baker1, Mark W Landis, Philip W Hinds.   

Abstract

The most well understood function of the D-type cyclins is to activate the G(1) kinases, cdk4 and cdk6, and target the retinoblastoma gene product (pRb) for phosphorylation and inactivation. pRb can suppress S phase entry, cause a transient G(1) arrest following DNA damage, and is critical in establishing terminal cell cycle withdrawal in cells exposed to differentiation or senescence-inducing signals. Each of these functions of pRb can be demonstrated in cultured cells derived from human tumors that have suffered RB1 gene inactivation. In such in vitro assays, coexpression of D type cyclins has been shown to inhibit the function of pRb, likely reflecting an oncogenic role of cyclin D1 in vivo. Two regions of cyclin D, the LxCxE pRb-binding motif, and the cyclin box, are thought to be critical for the proper function of cyclin D. Here we show that the LxCxE motif is dispensable in cyclin D1 for all functions tested, but is required by cyclin D2. This observation suggests that there is a functional difference between cyclins D1 and D2 in pRb regulation, and argues against complete functional redundancy of these D cyclins. In addition, the ability of cyclins D1 and D2 to activate cdk partners is required for induction of pRb phosphorylation and S phase entry. However, mutant forms of cyclins D1 and D2 that are incapable of activating kinase partners were still able to prevent pRb-induced senescence. Thus, D cyclins have both kinase-dependent and kinase-independent mechanisms of interfering with proliferation arrest and senescence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684604

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

Review 1.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

2.  Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium.

Authors:  Jonathan F Wilkey; Glenn Buchberger; Kirsten Saucier; Salony M Patel; Ellen Eisenberg; Hiroshi Nakagawa; Carmen Z Michaylira; Anil K Rustgi; Sanjay M Mallya
Journal:  Mol Carcinog       Date:  2009-09       Impact factor: 4.784

Review 3.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

4.  CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G1 phase to initiate a new cell cycle in HeLa cells.

Authors:  Huabo Chen; Xiaowei Xu; Guopeng Wang; Boyan Zhang; Gang Wang; Guangwei Xin; Junjun Liu; Qing Jiang; Hongyin Zhang; Chuanmao Zhang
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

5.  Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration.

Authors:  Shuyuan Chen; Masayuki Shimoda; Jiaxi Chen; Shinichi Matsumoto; Paul A Grayburn
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

6.  Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells.

Authors:  Florian A Siebzehnrubl; Rolf Buslei; Ilker Y Eyupoglu; Sebastian Seufert; Eric Hahnen; Ingmar Blumcke
Journal:  Exp Brain Res       Date:  2007-01-10       Impact factor: 1.972

7.  Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

Authors:  Shuyuan Chen; Raul A Bastarrachea; Brad J Roberts; V Saroja Voruganti; Patrice A Frost; Edna J Nava-Gonzalez; Hector E Arriaga-Cazares; Jiaxi Chen; Pintong Huang; Ralph A DeFronzo; Anthony G Comuzzie; Paul A Grayburn
Journal:  Cell Cycle       Date:  2014-02-10       Impact factor: 4.534

8.  Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Authors:  Da-Zhi Liu; Xi-Yuan Cheng; Bradley P Ander; Huichun Xu; Ryan R Davis; Jeffrey P Gregg; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2008-02-09       Impact factor: 5.996

9.  Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.

Authors:  Lei Shi; Siqing Wang; Maurizio Zangari; Hongwei Xu; Thai M Cao; Chunjiao Xu; Yong Wu; Fang Xiao; Yinghong Liu; Ye Yang; Mohamed Salama; Guiyuan Li; Guido Tricot; Fenghuang Zhan
Journal:  Oncotarget       Date:  2010-05

10.  Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.

Authors:  Etsuo Susaki; Keiko Nakayama; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.